Delayed presentation of iatrogenic ventriculoperitoneal shunt transection following laparoscopic weight loss surgery in a patient with idiopathic intracranial hypertension.

Idiopathic intracranial hypertension Intracranial hypertension Pseudotumor cerebri Ventriculoperitoneal shunt Weight reduction surgery

Journal

Annals of the Royal College of Surgeons of England
ISSN: 1478-7083
Titre abrégé: Ann R Coll Surg Engl
Pays: England
ID NLM: 7506860

Informations de publication

Date de publication:
Jan 2019
Historique:
pubmed: 6 10 2018
medline: 4 1 2019
entrez: 6 10 2018
Statut: ppublish

Résumé

Idiopathic intracranial hypertension is strongly associated with central obesity and consequential raised intra-abdominal pressure. If left untreated it poses significant risk to vision and can eventually cause blindness. Owing to its pathophysiology, this condition is managed by both medical and surgical specialities. When medical management fails neurosurgeons commonly treat idiopathic intracranial hypertension by permanent cerebrospinal fluid peritoneal shunting. Weight reduction surgery provides patients who are obese with a multitude of benefits and it is not uncommon for the general surgeon to be presented with a patient with idiopathic intracranial hypertension and a cerebrospinal fluid peritoneal shunt in place. This provides a potential challenging situation in weight-loss surgical procedures. We describe an interesting case where laparoscopic bariatric surgery resulted in transection of the abdominal catheter with a delayed presentation of recurrent symptoms and an abdominal cerebrospinal fluid collection in a patient with idiopathic intracranial hypertension. We discuss how this could be avoided and its management.

Identifiants

pubmed: 30286641
doi: 10.1308/rcsann.2018.0147
pmc: PMC6303825
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e5-e7

Références

J Neurosurg. 2004 Nov;101(5):878-80
pubmed: 15540933
Neurosurgery. 2005 Jul;57(1):97-108; discussion 97-108
pubmed: 15987545
J Neuroimmunol. 2008 Sep 15;201-202:212-20
pubmed: 18676028
Surg Endosc. 2013 Jul;27(7):2312-20
pubmed: 23389070
Neurology. 1996 Jan;46(1):198-202
pubmed: 8559374

Auteurs

U A Khan (UA)

King's College Hospital, Department of Neurosurgery , London , UK.

A Giamouriadis (A)

King's College Hospital, Department of Neurosurgery , London , UK.

R S Bhangoo (RS)

King's College Hospital, Department of Neurosurgery , London , UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH